Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06801626
PHASE3

Novel Strategies for Reducing Burn Scar Itch

Sponsor: The University of Texas Medical Branch, Galveston

View on ClinicalTrials.gov

Summary

The purpose of the study is to see whether using diphenhydramine (Benadryl), famotidine (Pepcid), and cromolyn sodium will decrease burn scar itch.

Key Details

Gender

All

Age Range

18 Years - 80 Years

Study Type

INTERVENTIONAL

Enrollment

44

Start Date

2025-03-01

Completion Date

2027-11-01

Last Updated

2025-09-24

Healthy Volunteers

No

Interventions

COMBINATION_PRODUCT

Famotidine and 4% topical cromolyn sodium

Patients will be instructed to take a 20mg famotidine capsule twice daily, and to use the lotion (4% cromolyn sodium) twice daily.

OTHER

Placebo

Treatment with active H1 antihistamine plus administration of placebo famotidine and placebo cromolyn sodium.

Locations (1)

University of Texas Medical Branch, Galveston

Galveston, Texas, United States